文献速递儿科影像神经MR

识别MYCN扩增RB1野生型视网膜母细胞瘤的MRI特征

MRI Features for Identifying MYCN-amplified RB1 Wild-type Retinoblastoma.
PubMed 文献 · Radiology · 2023-05-16

这项回顾性多中心病例对照研究纳入110例儿童(22例MYCN扩增RB1野生型视网膜母细胞瘤,88例RB1-/-对照),旨在定义前者的MRI表型并评估定性MRI特征识别该遗传亚型的能力。结果显示MYCN扩增RB1野生型肿瘤多位于周边、呈斑块或多形性、边缘不规则、伴广泛视网膜皱褶及玻璃体包裹,并常见瘤周出血、伴液-液平面的视网膜下出血和明显前房强化。作者认为这些特征可能有助于早期识别该亚型并改善个体化治疗的患者选择。

要点

  • MYCN扩增RB1野生型视网膜母细胞瘤常位于周边(17例中10例,特异度97%,P < .001)。
  • 瘤周出血(21例中17例,特异度88%,P < .001)与伴液-液平面的视网膜下出血(22例中8例,特异度95%,P = .005)提示该亚型。
  • 广泛视网膜皱褶伴玻璃体包裹(特异度94%,P < .001)及明显前房强化(21例中13例,特异度80%,P = .008)亦为该亚型特征。

核心结论

  • MYCN扩增RB1野生型视网膜母细胞瘤具有独特的MRI特征,可能有助于早期识别这些肿瘤,并可能在未来改善个体化治疗的患者选择。

研究设计与样本

  • 回顾性多中心病例对照研究,纳入10家视网膜母细胞瘤转诊中心的110例患儿,其中MYCN扩增RB1野生型22例、RB1-/-对照88例(病例对照比1:4),扫描采集时间为2001年6月至2021年2月,扫描收集时间为2018年5月至2021年10月。

关键影像表现/征象

  • MYCN扩增RB1野生型视网膜母细胞瘤典型位于周边(17例中10例,特异度97%,P < .001)。
  • 呈斑块或多形性(22例中20例,特异度51%,P = .011),伴边缘不规则(22例中16例,特异度70%,P = .008)。
  • 伴广泛视网膜皱褶及玻璃体包裹(特异度94%,P < .001)。
  • 伴瘤周出血(21例中17例,特异度88%,P < .001)。
  • 伴视网膜下出血及液-液平面(22例中8例,特异度95%,P = .005),并见明显前房强化(21例中13例,特异度80%,P = .008)。

诊断标准与关键数值

  • 周边位置识别MYCN扩增RB1野生型视网膜母细胞瘤的敏感度原文未报告,特异度97%(P < .001)。
  • 斑块或多形性形态的特异度51%(P = .011),边缘不规则的特异度70%(P = .008)。
  • 广泛视网膜皱褶伴玻璃体包裹的特异度94%(P < .001)。
  • 瘤周出血的特异度88%(P < .001),伴液-液平面的视网膜下出血的特异度95%(P = .005),明显前房强化的特异度80%(P = .008)。

临床应用与阅片要点

  • 阅片时关注肿瘤是否位于周边、呈斑块或多形性、边缘不规则,这些特征与MYCN扩增RB1野生型视网膜母细胞瘤相关。
  • 注意广泛视网膜皱褶伴玻璃体包裹、瘤周出血、伴液-液平面的视网膜下出血及明显前房强化等伴随征象。
  • 上述定性MRI特征可能有助于在活检未指示的情况下早期识别该遗传亚型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background MYCN-amplified RB1 wild-type (MYCNARB1+/+) retinoblastoma is a rare but clinically important subtype of retinoblastoma due to its aggressive character and relative resistance to typical therapeutic approaches. Because biopsy is not indicated in retinoblastoma, specific MRI features might be valuable to identify children with this genetic subtype. Purpose To define the MRI phenotype of MYCNARB1+/+ retinoblastoma and evaluate the ability of qualitative MRI features to help identify this specific genetic subtype. Materials and Methods In this retrospective, multicenter, case-control study, MRI scans in children with MYCNARB1+/+ retinoblastoma and age-matched children with RB1-/- subtype retinoblastoma were included (case-control ratio, 1:4; scans acquired from June 2001 to February 2021; scans collected from May 2018 to October 2021). Patients with histopathologically confirmed unilateral retinoblastoma, genetic testing (RB1/MYCN status), and MRI scans were included. Associations between radiologist-scored imaging features and diagnosis were assessed with the Fisher exact test or Fisher-Freeman-Halton test, and Bonferroni-corrected P values were calculated. Results A total of 110 patients from 10 retinoblastoma referral centers were included: 22 children with MYCNARB1+/+ retinoblastoma and 88 control children with RB1-/- retinoblastoma. Children in the MYCNARB1+/+ group had a median age of 7.0 months (IQR, 5.0-9.0 months) (13 boys), while children in the RB1-/- group had a median age of 9.0 months (IQR, 4.6-13.4 months) (46 boys). MYCNARB1+/+ retinoblastomas were typically peripherally located (in 10 of 17 children; specificity, 97%; P < .001) and exhibited plaque or pleomorphic shape (in 20 of 22 children; specificity, 51%; P = .011) with irregular margins (in 16 of 22 children; specificity, 70%; P = .008) and extensive retina folding with vitreous enclosure (specificity, 94%; P < .001). MYCNARB1+/+ retinoblastomas showed peritumoral hemorrhage (in 17 of 21 children; specificity, 88%; P < .001), subretinal hemorrhage with a fluid-fluid level (in eight of 22 children; specificity, 95%; P = .005), and strong anterior chamber enhancement (in 13 of 21 children; specificity, 80%; P = .008). Conclusion MYCNARB1+/+ retinoblastomas show distinct MRI features that could enable early identification of these tumors. This may improve patient selection for tailored treatment in the future. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Rollins in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Jansen, de Bloeme, Cardoen, et al. MRI Features for Identifying MYCN-amplified RB1 Wild-type Retinoblastoma. Radiology. 2023. PMID: 37191489. doi:10.1148/radiol.222264

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。